GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Cyclically Adjusted Price-to-FCF

Xtant Medical Holdings (FRA:XMS) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xtant Medical Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Cyclically Adjusted Price-to-FCF Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF falls into.



Xtant Medical Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Xtant Medical Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Xtant Medical Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.046/131.7762*131.7762
=-0.046

Current CPI (Mar. 2024) = 131.7762.

Xtant Medical Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -2.539 100.560 -3.327
201409 -1.867 100.428 -2.450
201412 -3.000 99.070 -3.990
201503 -3.206 99.621 -4.241
201506 -2.772 100.684 -3.628
201509 -4.950 100.392 -6.497
201512 -2.129 99.792 -2.811
201603 -1.522 100.470 -1.996
201606 -9.135 101.688 -11.838
201609 -4.039 101.861 -5.225
201612 -2.709 101.863 -3.505
201703 0.079 102.862 0.101
201706 -1.144 103.349 -1.459
201709 -0.452 104.136 -0.572
201712 0.256 104.011 0.324
201803 0.011 105.290 0.014
201806 -0.003 106.317 -0.004
201809 -0.074 106.507 -0.092
201812 0.111 105.998 0.138
201903 0.024 107.251 0.029
201906 0.026 108.070 0.032
201909 -0.102 108.329 -0.124
201912 -0.037 108.420 -0.045
202003 -0.141 108.902 -0.171
202006 -0.014 108.767 -0.017
202009 -0.020 109.815 -0.024
202012 0.003 109.897 0.004
202103 -0.019 111.754 -0.022
202106 0.016 114.631 0.018
202109 -0.013 115.734 -0.015
202112 -0.002 117.630 -0.002
202203 -0.015 121.301 -0.016
202206 -0.003 125.017 -0.003
202209 -0.028 125.227 -0.029
202212 -0.024 125.222 -0.025
202303 -0.023 127.348 -0.024
202306 -0.025 128.729 -0.026
202309 -0.028 129.860 -0.028
202312 -0.009 129.419 -0.009
202403 -0.046 131.776 -0.046

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xtant Medical Holdings  (FRA:XMS) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Xtant Medical Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (FRA:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines